Literature DB >> 7094388

Predisposing factors in Bell's palsy: a clinical study with reference to diabetes mellitus, hypertension, clotting mechanism and lipid disturbance.

L Abraham-Inpijn, P P Devriese, A A Hart.   

Abstract

The purpose of this study was to assess the frequency of risk factors for vascular disease like hypertension, lipid disturbances and diabetes mellitus in a group of patients with Bell's palsy. These patients were compared to patients with a peripheral facial paralysis of known origin. We did find a statistically significant difference between the Bell's palsy patients and their controls for cardio-vascular variables only. Hypertension proved to be by far the most important single discriminating variable.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7094388     DOI: 10.1111/j.1365-2273.1982.tb01569.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  5 in total

Review 1.  Focal and multifocal neuropathies.

Authors:  Rayaz A Malik
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

2.  The relationship between Bell's palsy and morphometric aspects of the facial nerve.

Authors:  Yoichiro Kondo; Hiroshi Moriyama; Shuichi Hirai; Ning Qu; Masahiro Itoh
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-15       Impact factor: 2.503

3.  Clinical characteristics and associated comorbidities in diabetic patients with cranial nerve palsies.

Authors:  D Greco; F Gambina; M Pisciotta; M Abrignani; F Maggio
Journal:  J Endocrinol Invest       Date:  2011-03-07       Impact factor: 4.256

4.  Potential misdiagnoses of Bell's palsy in the emergency department.

Authors:  Jahan Fahimi; Babak B Navi; Hooman Kamel
Journal:  Ann Emerg Med       Date:  2013-07-25       Impact factor: 5.721

5.  The association between Bell's palsy and rheumatoid arthritis: A longitudinal study.

Authors:  Sang-Yeon Lee; Jae-Sung Lim; Dong Jun Oh; Bumjung Park; Il-Seok Park; Hyo Geun Choi
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.